Public Health
In a bid to improve Department of Homeland Security (DHS) detection and interdiction capabilities for illicit drugs and their precursor chemicals, U.S. Sens. Gary Peters (D-MI) and Josh Hawley (R-MO) reintroduced the Enhancing DHS Drug Seizures Act last week.
Although the legislation was... Read More »
Justice Department officials have detailed the results of Operation SpecTor - described by authorities as a globally coordinated effort spanning three continents to disrupt dark web fentanyl and opioid trafficking.
“Operation SpecTor was a coordinated international law enforcement effort,... Read More »
Following up on a request for information (RFI) from U.S. Rep. Marionette Miller-Meeks (R-IA), in which she pushed for changes at the Centers for Disease Control and Prevention (CDC), the Johns Hopkins Center for Health Security delivered a proposal for a well-funded, appropriately authorized and... Read More »
Worried about the growing illicit use of the animal tranquilizer Xylazine, also known as Tranq, a group of senators and representatives introduced the TRANQ Research Act of 2023 this week to mandate the creation of new tests for its detection and improve understanding overall.
In the Senate,... Read More »
U.S. Sens. Todd Young (R-IN), Bill Hagerty (R-TN), and eight colleagues are espousing the benefits of reintroducing the Stop Fentanyl Border Crossings Act.
Specifically, the legislation adds drug smuggling as an additional basis for Title 42 immigration enforcement authority, preserving for... Read More »
The Drug Enforcement Administration (DEA) is espousing the benefits of its 24th National Prescription Drug Take Back Day on April 22.
“Thanks to our local and state partners, we collected in the past event in October more than 33,500 pounds," DEA Washington Division Special Agent in Charge... Read More »
Due to the rising threat of cyberattacks against the health and public health sector, the U.S. Department of Health and Human Services (HHS) this week released three new resources under its HHS 405(d) Program to aid cybersecurity efforts.
Together with the Health Sector Coordinating Council... Read More »
Xylazine, a non-opioid tranquilizer approved for veterinary use, was recently declared an emerging threat to the United States by Dr. Rahul Gupta, director of the White House Office of National Drug Control Policy (ONDCP), when combined with fentanyl.
While never approved for human use,... Read More »
The rising dependence that the United States has on many Chinese pharmaceuticals is worsening the nation’s drug shortage and creating a national security risk that several members of Congress want to disrupt.
Lawmakers, in fact, have introduced legislation in Congress from both sides of the... Read More »
U.S. Reps. Michael C. Burgess (R-TX) and Kathy Castor (D-FL) recently reintroduced the MISSION Zero Act, which would aid in addressing the emergency room care gap.
The bill would enable the Department of Defense (DoD) to continue assigning trauma surgeons to civilian trauma centers.
“The... Read More »
A bipartisan group of lawmakers recently introduced the Combating Illicit Xylazine Act, which seeks to classify the drug under Schedule III of the Controlled Substances Act.
U.S. Reps. August Pfluger (R-TX), Jimmy Panetta (D-CA), Gus Bilirakis (R-FL), Ken Buck (R-CO), and Chris Pappas (D-NH)... Read More »
U.S. Reps. Morgan Griffith (R-VA) and Bob Latta (R-OH) are commending the House of Representatives Energy and Commerce Committee's advancement of legislation addressing fentanyl analogues permanent scheduling.
Bill proponents indicated the Halt All Lethal Trafficking of (HALT) Fentanyl Act... Read More »
By measuring states’ current emergency readiness levels and data on weather-related disasters, vaccinations, and more, a new report from the nonprofit health policy organization Trust for America’s Health made a case for strengthening public health preparedness.
Of the greatest concerns to... Read More »
U.S. Customs and Border Protection (CBP) officials recently announced the thwarting of three recent major narcotics smuggling attempts
worth more than $5.7 million via the San Diego Field Office.
The first seizure involved a driver identified as a 25-year-old female in possession of a valid... Read More »
In its first week, the U.S. Department of Homeland Security’s (DHS) Operation Blue Lotus nabbed more than 900 pounds of fentanyl at the border in a major cooperative effort by federal, state, Tribal, and local partners.
“This Administration has a multi-pronged strategy to combat the scourge... Read More »
Responding to the severity of cyber threats to the healthcare sector, United States Sen. Gary Peters (D-MI), Chairman of the Homeland Security and Governmental Affairs Committee, convened a hearing this week to address those threats and what the government and providers can do to stop... Read More »
In the 2023 Intelligence Community Assessment (ICA), released last week, the U.S. Intelligence community made Anomalous Health Incidents (AHIs) – formerly and more popularly known as the Havana Syndrome – a primary focus, laying out the case that foreign adversaries are not likely behind the... Read More »
Hoping to address vulnerabilities in health systems throughout the United States, the Department of Health and Human Services (HHS) released a new cybersecurity implementation framework this week with specific steps for public and private healthcare organizations to pursue.
“Cyber incidents... Read More »
With a reauthorization due date of Sept. 30, 2023, for the Pandemic and All Hazards Preparedness Act (PAHPA), two House Energy and Commerce Committee members sought this week to get ahead of the issue with a request for information from public and private interests.
“Throughout COVID-19, our... Read More »
The Drug Enforcement Agency (DEA) is attributing a successful three-year investigation targeting the Sinaloa Drug Cartel to partnerships with the Arizona Attorney General’s Office and the Tempe Police Department.
To date, more than 150 individuals have been charged, with investigators having... Read More »
Defense Advanced Research Projects Agency (DARPA) officials are espousing the benefits of its Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program, which addresses blood supply shortages.
“When blood donations decline – as we have seen during the... Read More »
U.S. Reps. Morgan Griffith (R-VA), Bob Latta (R-OH), and Cathy McMorris Rodgers (R-WA) recently introduced the Halt All Lethal Trafficking of (HALT) Fentanyl Act, which seeks to permanently schedule fentanyl analogues while granting researchers the ability to conduct fentanyl substance... Read More »
As called for under the CARES Act stimulus bill of 2020, the Government Accountability Office (GAO) conducted an investigation of the U.S. Department of Health and Human Services’ (HHS) oversight practices surrounding research into pandemic pathogens and found cause for concern.
While such... Read More »
As lawmakers process the passage of the government funding bill at the tail end of December 2022, U.S. Sen. Susan Collins (R-ME) announced that major portions of the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act) were included in its... Read More »
Currently, immigration to the United States is still bound by the requirements of the Title 42 public health order enacted in March 2020, but while the legality of this remains bound up in court, the Department of Homeland Security (DHS) stated this week that it is preparing for a return to Title 8... Read More »
The National Institutes of Health (NIH) is touting the new Home Test to Treat program, a virtual community health intervention that provides free COVID-19 health services and treatments in selected communities.
“At-home testing for COVID-19 is now widely available in the United States, as are... Read More »
The U.S. Drug Enforcement Administration (DEA) said that, last year, the Louisville Division yielded the seizure of 184,382 fentanyl-laced, fake prescription pills and 316 pounds of Fentanyl powder.
“Fentanyl is a national problem, and it’s landed right on our doorstep,” DEA Louisville... Read More »
Drug Enforcement Administration (DEA) officials have detailed the Omaha Division's seizure of nearly 4.7 million lethal doses of fentanyl in both pill and powder form throughout 2022.
“The amount of fentanyl we’ve seized across our Division has far surpassed our totals from last year,” DEA... Read More »
In a civil complaint filed last week, the U.S. Department of Justice (DOJ) opened a nationwide lawsuit against AmerisourceBergen Corp. and two of its subsidiaries, which together form one of the largest pharmaceutical distributors, for violating federal law on the distribution of controlled... Read More »
In a move that will affect every jurisdiction in the United States, the Centers for Disease Control and Prevention (CDC) announced this week that $3.2 billion will be issued to state, local, and territorial jurisdictions to strengthen their public health workforce and its infrastructure.
The... Read More »
As part of its Antiviral Program for Pandemics (APP), meant to accelerate the discovery, development, and manufacturing of antivirals, the National Institute of Allergy and Infectious Diseases (NIAID) recently awarded more than $12 million to three institutions for new therapies.
These new... Read More »
U.S. Sens. Gary Peters (D-MI) and Rick Scott (R-FL) are commending the House of Representatives' passage of the Disaster Resiliency Planning Act, which now moves to President Joe Biden's desk to be signed into law.
The measure, which garnered Senate approval in June, requires federal agencies to... Read More »
Capitalistic values continue to hinder vaccine development, according to the World Health Organization’s (WHO) first report on the global vaccine market since COVID-19, with prioritizes vaccines not being developed due to limited profit potential and limited access for lower-income countries... Read More »
Pfizer and BioNTech announced updates from a Phase 2/3 clinical trial of their bivalent booster for the COVID-19 variants Omicron BA.4/BA.5 last week, pointing to the 4-fold higher emergence of neutralizing antibody titers among treated adults older than 55, comparative to the original COVID-19... Read More »
Biopharmaceutical company Soligenix, Inc. recently received an invitation from the Biomedical Advanced Research and Development Authority (BARDA) to submit a contract proposal for millions of dollars in development support for single vial, thermostabilized subunit vaccines for the Sudan ebolavirus... Read More »
